No Data
No Data
China National Accord Medicines Corporation Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sinopharm is consistent: report for the third quarter of 2024
Express News | China National Accord Medicines Says Q3 Net Profit Down 10.4% Y/Y
Sinopharm is consistent: quick performance report for the first three quarters of 2024
China National Accord Medicines Corporation (000028.SZ): Net income for the first three quarters was 1.066 billion yuan, a year-on-year decrease of 10.43%.
China National Accord Medicines Corporation (000028.SZ) released the third quarter performance report for 2024, reporting that the company achieved operating income during the reporting period...
Private Companies Invested in China National Accord Medicines Corporation Ltd. (SZSE:000028) Copped the Brunt of Last Week's CN¥2.5b Market Cap Decline
No Data
No Data